๐
Rxulti
brexpiprazole
Schizophrenia
โ
Authorised
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Rxulti is indicated for the treatment of schizophrenia in adult and adolescents aged 13 years and older.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/rxulti